Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Team
501-1000
employees, estimated range
Backers
1
F-Prime Capital
Momentum
0/100
no fresh signals
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
EurekaBio is a leading upstream core vendor in the field of Cell and Gene Therapy (CGT), focusing on innovative research and development of…
AvenCellSeries B $112M · 23 mo ago
Next generation immunotherapies for hard-to-treat cancers that are allogeneic and switchable.
Benefits platform for cell and gene therapies designed to provide sustainable access to life-saving medicines.
Anocca ABVenture round $41.8M · 13 mo ago • Founded 2014
Anocca is creating a pipeline of precision T-cell immunotherapies by combining its novel approach to T-cell biology, cutting-edge…
Cancer immunotherapy that turns cancer cells into biofactories minting their own destruction.
Asgard TherapeuticsSeries A $32.4M · 2 yr ago • 51-200 employees
Reprogramming is the next leap forward in cancer immunotherapy. Asgard Therapeutics is a Swedish private biotech company exploring direct…

Overview

Immuneel is advancing access to breakthrough cancer therapies in India, for India and the world.. Cell, gene, and immunotherapies are transforming the landscape of cancer care, bringing real hope to millions worldwide.